Search Results - "Rami-Merhar, Birgit"

Minimum effective low dose of antithymocyte globulin in people aged 5–25 years with recent-onset stage 3 type 1 diabetes (MELD-ATG): a phase 2, multicentre, double-blind, randomised, placebo-controlled, adaptive dose-ranging trial.

Authors: Mathieu, Chantal Wych, Julie Hendriks, A Emile J et al.

Source: Lancet. 9/27/2025, Vol. 406 Issue 10510, p1375-1388. 14p.

Subjects: Type 1 diabetes, Immunosuppressive agents, Experimental design, Young adults, Clinical trials, Therapeutics, Biomarkers

Prevalence of cardiovascular risk factors in children and adolescents with type 1 diabetes in Austria.

Authors: Steigleder-Schweiger, Claudia Rami-Merhar, Birgit Waldhör, Thomas et al.

Source: European Journal of Pediatrics. Aug2012, Vol. 171 Issue 8, p1193-1202. 10p. 3 Charts, 1 Graph.

Time trends in incidence of diabetes mellitus in Austrian children and adolescents <15 years (1989‐2017).

Authors: Rami‐Merhar, Birgit Hofer, Sabine E. Fröhlich‐Reiterer, Elke et al.

Source: Pediatric Diabetes. Aug2020, Vol. 21 Issue 5, p720-726. 7p. 2 Charts, 3 Graphs.

Cambridge hybrid closed‐loop use in very young children with type 1 diabetes: Parental expectancies during long‐term home use.

Authors: Vidou, Alexia Pit‐ten Cate, Ineke M. Campbell, Fiona M. et al.

Source: Diabetic Medicine. Jul2026, p1. 8p. 1 Illustration.

The Cross-Link between Adipokines, Insulin Resistance and Obesity in Offspring of Diabetic Pregnancies.

Authors: Bozkurt, Latife Göbl, Christian S. Rami-Merhar, Birgit et al.

Source: Hormone Research in Paediatrics. Dec2016, Vol. 86 Issue 5, p300-308.

Gestational diabetes and maternal obesity suggestively priming children's premature atherosclerosis: Is it the mother fault?

Authors: Rami-Merhar, Birgit Zierfuss, Bernhard Schernthaner, Gerit-Holger

Source: Atherosclerosis (00219150). May2019, Vol. 284, p214-215. 2p.

888-P: Day vs. Nighttime Performance of Continuous Glucose Monitoring Systems in Children with Type 1 Diabetes during a Diabetes Summer Camp.

Authors: RAMI-MERHAR, BIRGIT NAGL, KATRIN BERGER, GABRIELE et al.

Source: Diabetes. 2020 Supplement, Vol. 69, pN.PAG-N.PAG. 1p.

HbA1c Variability as an Independent Risk Factor for Diabetic Retinopathy in Type 1 Diabetes: A German/Austrian Multicenter Analysis on 35,891 Patients.

Authors: Hermann, Julia M. Hammes, Hans-Peter Rami-Merhar, Birgit et al.

Source: PLoS ONE. Mar2014, Vol. 9 Issue 3, p1-5. 5p.

Head-to-Head Comparison of Two Automated Insulin Delivery Systems in Children with Type 1 Diabetes during a 2-Week Summer Camp: An Exploratory Prospective Study.

Authors: Bünzel, Katharina Sanfilippo, Sabrina Moser, Othmar et al.

Source: Hormone Research in Paediatrics. Sep2025, p1-9. 9p. 1 Illustration.

Eighteen-Month Hybrid Closed-Loop Use in Very Young Children With Type 1 Diabetes: A Single-Arm Multicenter Trial.

Authors: Ware, Julia Allen, Janet M. Boughton, Charlotte K. et al.

Source: Diabetes Care. Dec2024, Vol. 47 Issue 12, p2189-2195. 7p.

Genetic testing in inherited endocrine disorders: joint position paper of the European reference network on rare endocrine conditions (Endo-ERN).

Authors: Eggermann, Thomas Elbracht, Miriam Kurth, Ingo et al.

Source: Orphanet Journal of Rare Diseases. 6/8/2020, Vol. 15 Issue 1, p1-16. 16p.

Expected Basal Insulin Requirement During Continuous Subcutaneous Insulin Infusion Therapy by Age Group, Sex, and Body Mass Index, Based on 25,718 Young People with Type 1 Diabetes in the DPV Registry.

Authors: Biester, Torben Eckert, Alexander Becker, Marianne et al.

Source: Diabetes Technology & Therapeutics. Nov2023, Vol. 25 Issue 11, p774-781. 8p.

Ongoing Increase in Incidence of Diabetes in Austrian Children and Adolescents (1989–2021): Results from a Nationwide Registry.

Authors: Nagl, Katrin Waldhör, Thomas Hofer, Sabine E. et al.

Source: Pediatric Diabetes. 8/18/2023, p1-7. 7p.

Cambridge Hybrid Closed-Loop System in Very Young Children With Type 1 Diabetes Reduces Caregivers' Fear of Hypoglycemia and Improves Their Well-Being.

Authors: de Beaufort, Carine Schierloh, Ulrike Thankamony, Ajay et al.

Source: Diabetes Care. Dec2022, Vol. 45 Issue 12, p3050-3053. 4p. 1 Chart.

Parents' views about healthcare professionals having real‐time remote access to their young child's diabetes data: Qualitative study.

Authors: Kimbell, Barbara Rankin, David Hart, Ruth I. et al.

Source: Pediatric Diabetes. Sep2022, Vol. 23 Issue 6, p799-808. 10p.

Parents' experiences of using remote monitoring technology to manage type 1 diabetes in very young children during a clinical trial: Qualitative study.

Authors: Hart, Ruth I. Kimbell, Barbara Rankin, David et al.

Source: Diabetic Medicine. Jul2022, Vol. 39 Issue 7, p1-12. 12p.

Increased referrals for congenital hyperinsulinism genetic testing in children with trisomy 21 reflects the high burden of non‐genetic risk factors in this group.

Authors: Hewat, Thomas I. Laver, Thomas W. Houghton, Jayne A. L. et al.

Source: Pediatric Diabetes. Jun2022, Vol. 23 Issue 4, p457-461. 5p.

International comparison of glycaemic control in people with type 1 diabetes: an update and extension.

Authors: Prigge, Regina McKnight, John A. Wild, Sarah H. et al.

Source: Diabetic Medicine. May2022, Vol. 39 Issue 5, p1-12. 12p.

Understanding the clinical implications of differences between glucose management indicator and glycated haemoglobin.

Authors: Gomez‐Peralta, Fernando Choudhary, Pratik Cosson, Emmanuel et al.

Source: Diabetes, Obesity & Metabolism. Apr2022, Vol. 24 Issue 4, p599-608. 10p.

Declining Frequency of Acute Complications Associated with Tubeless Insulin Pump Use: Data from 2,911 Patients in the German/Austrian Diabetes Patienten Verlaufsdokumentation Registry.

Authors: Biester, Torben Schwandt, Anke Heidtmann, Bettina et al.

Source: Diabetes Technology & Therapeutics. Aug2021, Vol. 23 Issue 8, p527-536. 10p.